Publicaciones en las que colabora con Antonio Salas Ellacuriaga (4)
2024
-
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828
2022
-
A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity
Environmental Research, Vol. 210
-
Characterisation of the blood RNA host response underpinning severity in COVID-19 patients
Scientific Reports, Vol. 12, Núm. 1